Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes

Chest

Volumn 144, Issue 3, 2013, Pages 1018-1025

  Crotti, Stefania ^a   Iotti, Giorgio A ^c   Lissoni, Alfredo ^a   Belliato, Mirko ^c   Zanierato, Marinella ^c   Chierichetti, Monica ^a   Di Meo, Guendalina ^c   Meloni, Federica ^c,d   Pappalettera, Marilena ^a   Nosotti, Mario ^a   Santambrogio, Luigi ^a   Viganò, Mario ^c   Braschi, Antonio ^c,d   Gattinoni, Luciano ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXTRACORPOREAL OXYGENATION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; NONINVASIVE VENTILATION; ORGAN ALLOCATION WAITING TIME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL; TIME;

EID: 84884293197     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1141     Document Type: Article

References (22)

1. Jackson A, Cropper J, Pye R, Junius F, Malouf M, Glanville A. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant. 2008; 27 (3): 348-352.
2. Jurmann MJ, Haverich A, Demertzis S, Schaefers HJ, Wagner TO, Borst HG. Extracorporeal membrane oxygenation as a bridge to lung transplantation. Eur J Cardiothorac Surg. 1991 ; 5 (2): 94-97.
3. Fischer S, Hoeper MM, Tomaszek S, et al. Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: the initial Hannover experience. ASAIO J. 2007 ; 53 (2): 168-170.
4. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg. 2007 ; 31 (3): 468-473.
5. Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg. 2006 ; 131 (3): 719-723.
6. Hämmäinen P, Schersten H, Lemström K, et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant. 2011 ; 30 (1): 103-107.
7. Bermudez CA, Rocha RV, Zaldonis D, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg. 2011 ; 92 (4): 1226-1231.
8. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med. 2012 ; 185 (7): 763-768.
9. Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation. 2012 ; 93 (7): 729-736.
10. Oto T, Rosenfeldt F, Rowland M, et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg. 2004; 78(4): 1230-1235.
11. Strueber M. Extracorporeal support as a bridge to lung transplantation. Curr Opin Crit Care. 2010 ; 16 (1): 69-73.
12. Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant. 2010 ; 10 (9): 2173-2178.
13. Egan TM, Kotloff RM. Pro/Con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest. 2005 ; 128 (1): 407-415.
14. Russo MJ, Iribarne A, Hong KN, et al. High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest. 2010 ; 137 (3): 651-657.
15. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 ; 22 (7): 707-710.
16. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care. 2008 ; 12 (6): R161.
17. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D ; ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Defi nition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005 ; 24 (10): 1454-1459.
18. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011 ; 10 (10): 931-941.
19. Levey AS, Stevens LA, Schmid CH, et al ; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular fi ltration rate. Ann Intern Med. 2009 ; 150 (9): 604-612.
20. Human Medicines Evaluation Unit. ICH topic E6: Guideline for Good Clinical Practice. London, England: European Agency for the Evaluation of Medical Products; 1996 :17-20.
21. Thernau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY : Springer ; 2000.
22. Singer JP, Blanc PD, Hoopes C, et al. The impact of pretransplant mechanical ventilation on short-and long-term survival after lung transplantation. Am J Transplant. 2011 ; 11 (10): 2197-2204.